Skip to main content

Pharmacogenetic Testing Study from Harvard Medical School

| Article

Study from Harvard Medical School reveals that Pharmacogenetic Testing for Statin Side Effects Doesn't Result in Worse Blood Cholesterol Levels.

"This study provides reassurance that patients and providers can use pharmacogenetic testing in a way that maximizes its benefits while avoiding harmful unintended consequences," lead author Jason Vassy, an assistant professor of medicine at Harvard, said in a statement."

Lern more ...

Article on genomeweb